Compound Information | SONAR Target prediction | Name: | CHOLESTAN-3-ONE | Unique Identifier: | SPE00270088 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C27H46O | Molecular Weight: | 341.296 g/mol | X log p: | 1.754 (online calculus) | Lipinksi Failures | 0 | TPSA | 17.07 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 1 | Rotatable Bond Count: | 5 | Canonical Smiles: | CC(C)CCCC(C)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C | Source: | ex minor mammalian sterol | Generic_name: | 5ALPHA-ANDROSTAN-3,17-DIONE | Chemical_iupac_name: | 5ALPHA-ANDROSTAN-3,17-DIONE | Drug_type: | Experimental | Drugbank_id: | EXPT00262 | Drug_category: | Estradiol 17 Beta-Dehydrogenase 1 inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
BCK1 |
Replicates: |
2 |
Raw OD Value: r im |
0.6546±0.0121622 |
Normalized OD Score: sc h |
1.0609±0.016406 |
Z-Score: |
1.1877±0.2996 |
p-Value: |
0.245382 |
Z-Factor: |
-1.20973 |
Fitness Defect: |
1.4049 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 6|D8 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 25.00 Celcius | Date: | 2006-03-24 YYYY-MM-DD | Plate CH Control (+): | 0.038425±0.00113 | Plate DMSO Control (-): | 0.654025±0.02504 | Plate Z-Factor: | 0.8488 |
| png ps pdf |
7056784 |
(5S,8R,9S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,1 7-tetradecahydrocyclopenta[a]phenanthren-3-one |
7057894 |
(5S,8S,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,1 7-tetradecahydrocyclopenta[a]phenanthren-3-one |
7057963 |
(2S)-2-methylcyclohexan-1-one |
7057964 |
(3S)-3-methylcyclohexan-1-one |
7057991 |
(2S,6S)-2,6-dimethylcyclohexan-1-one |
7060916 |
(2R)-2-methylcyclododecan-1-one |
internal high similarity DBLink | Rows returned: 17 | 1 2 3 Next >> |
active | Cluster 5819 | Additional Members: 6 | Rows returned: 0 | |
|